Prevalence, Causes, and Predictors of 30‐Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock: Findings From the 2013–2014 National Readmissions Database

Background Prior studies have shown that survivors of acute myocardial infarction (AMI) complicated by cardiogenic shock are likely to have increased risk of readmissions in the early post‐discharge period. However, the contemporary prevalence, reasons, and predictors of 30‐day readmissions are not well known. Methods and Results Hospitalizations for a primary diagnosis of AMI complicated by cardiogenic shock, and discharged alive, were identified in the 2013 and 2014 Nationwide Readmissions Databases. Prevalence and reasons for 30‐day unplanned readmissions were investigated. A hierarchical logistic regression model was used to identify independent predictors of 30‐day readmissions. Among 1 116 933 patient hospitalizations with AMI, 39 807 (3.6%) had cardiogenic shock and were discharged alive. Their 30‐day readmission rate was 18.6%, with a median time for readmission 10 days post discharge. Predictors of readmission included: non–ST‐segment elevation myocardial infarction, female sex, low‐income status, nonprivate insurance, chronic renal failure, long‐term ventricular assist device or intra‐aortic balloon placement, and tachyarrhythmia. The majority of readmissions were attributable to cardiac‐related causes (52%); heart failure being the most frequent cardiac cause (39% of all cardiac causes). Noncardiac‐related readmissions included infections (14.9%), bleeding (5.3%), and respiratory causes (4.9%). The median cost per readmission was $9473 US dollars ($5037–20 199). Conclusions Among survivors of AMI complicated by cardiogenic shock who were discharged from hospital, almost 1 in 5 are readmitted at 30 days, mainly because of cardiac reasons such as heart failure and new AMI. The risk of readmission was associated with certain baseline patient/hospital characteristics.

[1]  H. White,et al.  Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[2]  I. Elgendy,et al.  Early Invasive Strategy and In‐Hospital Survival Among Diabetics With Non‐ST‐Elevation Acute Coronary Syndromes: A Contemporary National Insight , 2017, Journal of the American Heart Association.

[3]  M. Wolf,et al.  Health literacy and 30-day hospital readmission after acute myocardial infarction , 2015, BMJ Open.

[4]  J. Messenger,et al.  Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. , 2016, JACC. Cardiovascular interventions.

[5]  Deepak L. Bhatt,et al.  Differences in the Profile, Treatment, and Prognosis of Patients With Cardiogenic Shock by Myocardial Infarction Classification: A Report From NCDR , 2013, Circulation. Cardiovascular quality and outcomes.

[6]  C. Granger,et al.  Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. , 2016, Journal of the American College of Cardiology.

[7]  R. Washington,et al.  Trends in Hospital Readmissions for Four High-Volume Conditions, 2009–2013 , 2006 .

[8]  Y. Zhang,et al.  Medication adherence and readmission after myocardial infarction in the Medicare population. , 2014, American Journal of Managed Care.

[9]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[10]  Eric J. Topol,et al.  Clinical studyContemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience , 1995 .

[11]  A. Jaffe,et al.  Thirty-Day Rehospitalizations After Acute Myocardial Infarction , 2012, Annals of Internal Medicine.

[12]  E. Peterson,et al.  Association of Early Physician Follow-Up and 30-Day Readmission After Non–ST-Segment–Elevation Myocardial Infarction Among Older Patients , 2013, Circulation.

[13]  Deepak L. Bhatt,et al.  Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials. , 2017, JACC. Cardiovascular interventions.

[14]  E R Bates,et al.  Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[15]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[16]  D. McManus,et al.  Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction , 2016, Circulation. Cardiovascular quality and outcomes.

[17]  K. Alexander,et al.  Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shock. , 2013, American heart journal.

[18]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[19]  I. Elgendy,et al.  Gender Impact on 30-Day Readmissions After Hospitalization With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the 2013 to 2014 National Readmissions Database). , 2017, The American journal of cardiology.

[20]  I. Elgendy,et al.  Early Invasive Versus Initial Conservative Strategies for Women with Non-ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis. , 2017, The American journal of medicine.

[21]  P. Quandalle,et al.  Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry , 2014, Critical Care.

[22]  J. Hochman,et al.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. , 2005, JAMA.